Ambrx Biopharma American Price Prediction
| AMAMDelisted Stock | USD 15.73 0.71 4.73% |
Oversold Vs Overbought
37
Oversold | Overbought |
Using Ambrx Biopharma hype-based prediction, you can estimate the value of Ambrx Biopharma American from the perspective of Ambrx Biopharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ambrx Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Ambrx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Ambrx Biopharma after-hype prediction price | USD 15.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Ambrx |
Ambrx Biopharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Ambrx Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ambrx Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ambrx Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Ambrx Biopharma Estimiated After-Hype Price Volatility
In the context of predicting Ambrx Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ambrx Biopharma's historical news coverage. Ambrx Biopharma's after-hype downside and upside margins for the prediction period are 15.73 and 15.73, respectively. We have considered Ambrx Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Ambrx Biopharma is very steady at this time. Analysis and calculation of next after-hype price of Ambrx Biopharma American is based on 3 months time horizon.
Ambrx Biopharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Ambrx Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ambrx Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ambrx Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 13 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
15.73 | 15.73 | 0.00 |
|
Ambrx Biopharma Hype Timeline
Ambrx Biopharma American is presently traded for 15.73. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ambrx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.0%. %. The volatility of related hype on Ambrx Biopharma is about 0.0%, with the expected price after the next announcement by competition of 15.73. About 98.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Ambrx Biopharma American had 1:1 split on the 12th of October 2023. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.Ambrx Biopharma Related Hype Analysis
Having access to credible news sources related to Ambrx Biopharma's direct competition is more important than ever and may enhance your ability to predict Ambrx Biopharma's future price movements. Getting to know how Ambrx Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ambrx Biopharma may potentially react to the hype associated with one of its peers.
Ambrx Biopharma Additional Predictive Modules
Most predictive techniques to examine Ambrx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ambrx using various technical indicators. When you analyze Ambrx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ambrx Biopharma Predictive Indicators
The successful prediction of Ambrx Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ambrx Biopharma American, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ambrx Biopharma based on analysis of Ambrx Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ambrx Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ambrx Biopharma's related companies.
Story Coverage note for Ambrx Biopharma
The number of cover stories for Ambrx Biopharma depends on current market conditions and Ambrx Biopharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ambrx Biopharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ambrx Biopharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Ambrx Biopharma Short Properties
Ambrx Biopharma's future price predictability will typically decrease when Ambrx Biopharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ambrx Biopharma American often depends not only on the future outlook of the potential Ambrx Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ambrx Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.6 M | |
| Cash And Short Term Investments | 84.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |